Sphingolipids consist of glycosphingolipids (GSLs) and sphingomyelin (SM) that have different polar head groups, a sugar chain and phosphocholine, respectively. It has been reported that GSLs are involved in cell growth, differentiation, and adhesion.
In pathogenesis, GSLs are receptors for various types of virulent agents such as bacteria and viruses. [7] [8] [9] [10] [11] Among GSLs, some gangliosides, GSLs containing sialic acids are dominant receptors for influenza viruses. [8] [9] [10] [11] Influenza viruses attach to the receptor molecules such as gangliosides and/or glycoproteins on the host cell surface and enter the cells. In the infected cells, viral genome is replicated and viral proteins are synthesized by host translational systems. These materials are carried and assembled along vesicular trafficking systems in the cells. Finally matured viral particles go out from the host cells by the action of neuraminidase, a viral glycoprotein. 11) Recently, several lines of evidence demonstrated new aspects of cellular function of sphingolipids. They are characteristically enriched in microdomains on the cellular membranes together with cholesterol and are indispensable for trafficking of secretary vesicles to the apical surface of epithelial cells, such as Madin-Darby canine kidney (MDCK) cells. [12] [13] [14] [15] [16] [17] [18] It is also well known that transfected hemagglutinin (HA) is a specific marker for subcellular organelles related with trafficking vesicles to the apical surface, such as trans-Golgi network. 19, 20) The association of transmembrane domain of the transfected HA with sphingolipids in vesicular membrane is critically involved in the trafficking of this molecule to the apical surface. 13, 14) The participation of sphingolipid-enriched microdomains is, however undefined in the infection, especially the maturation of influenza viruses in the host cells.
In this study, we used two different inhibitors of sphingolipid metabolism to address the issue. The treatment with fumonisin B1 (FB1) suppresses all complex sphingolipids with polar head groups including GSLs and SM in the cells. 21, 22) 
pholino-1-propanol (PDMP) inhibits the synthesis of GSLs alone, but not SM. 23) By additional treatment of MDCK cells with the inhibitors post viral adsorption, but not pretreatment alone, we observed significant reduction of viral infection. Compositional analysis of cellular sphingolipids and immunocytochemical staining strongly suggest the involvement of sphingolipids in the propagation of influenza viruses in the host cells.
MATERIALS AND METHODS

Reagents
were purchased from Calbiochem, Sigma and Toronto Research Chemicals Inc., respectively. Anti-HA monoclonal antibody (clone 12CA5) was obtained from Roche Diagnostics Corp. All other chemicals were of the highest purity available.
Viruses Influenza viruses from human isolates, A/PR/8/34 (H1N1), A/Memphis/1/71 (H3N2), and B/Lee/40 were used for this study. Virus strains were propagated in the allantoic cavity of 11-d-old chicken eggs for 48 h at 35°C and purified by sucrose density gradient centrifugation. 8, 9, 24) Cell Culture and Virus Inoculation MDCK cells were maintained in MEM containing 10% fetal bovine serum. MDCK cells were seeded at 0.5-1ϫ10 4 cells/well in 96-well plastic plates and cultured at 37°C. The TCID 50 (50% tissue-culture infectious dose) of each virus to MDCK cells was determined as described previously. 25) The cells were then inoculated with the virus at 100TCID 50 and further cultured for 20 h, followed by the assays of antiviral activity. The treatment with inhibitors was carried out by two different protocols as follows (Chart 1). For the "pretreatment" of cells, the cells were seeded in 96-well plastic plates and cultured for 40 to 48 h at 37°C in the presence or absence of the inhibitors. The cells were then inoculated with the virus solution. For "pre-and post-treatment" of the cells, the cells were seeded in 96-well plastic plates and cultured for 24 h at 37°C in the presence or absence of the inhibitors. The cells were then inoculated with the virus and further cultured for 20 h with or without the indicated concentrations of the inhibitors. Viral infection was quantified by the measurement of lactate dehydrogenase (LDH) activity released from the infected cells.
Neutralization of Infection of MDCK Cells by Influenza Virus
The neutralization assay for human influenza virus infection to MDCK cells was carried out using a slightly modified calorimetric assay as described previously. 26) Briefly, viral-induced cytopathic effect was monitored by light microscopy. The LDH activity of released from MDCK cells was determined. The culture medium (40 ml) was mixed with 5-fold concentrated PBS (10 ml). The plates were pre-incubated at 37°C for 5 min. LDH reagent (50 ml) was added and the mixture was incubated 37°C for 10 min. The reaction was stopped by the addition of 100 ml of 0.5 M HCl. The absorbance was measured at 550 nm with 630 nm as a reference wavelength. Each experiment was carried out in duplicate.
Lipid Analysis The analysis for lipid composition in MDCK cells treated with or without the inhibitors was performed as described previously. 27) Briefly, cells (1-2ϫ10 7 ) were harvested and total lipids were extracted with a mixture of chloroform/methanol/water (1 : 1 : 0.1, by vol.). Lipids equivalent to 3-4ϫ10 5 cells were applied per lane on TLC. The solvent systems used in this study were chloroform/ methanol/acetic acid/water (25 : 15 : 4 : 2, by vol.) for phospholipid and chloroform/methanol/12 mM MgCl 2 (5 : 4 : 1, by vol.) for GSL analysis. Phospholipids and GSLs were detected with Zittmer and orcinol reagents, respectively. The amounts of each lipid were quantified at 650 nm for phospholipids and at 540 nm for GSLs using a TLC-densitometer, CS-9000 (Shimadzu, Japan).
Immunofluorescence Analysis All immunocytochemical reactions were carried out at room temperature. MDCK cells were seeded at 5ϫ10 3 cells/well in an 8-chamber glass slide (Lab-Tek, Nunc Inc.) and cultured for 24 h at 37°C. The cells were pretreated for 24 or 44 h with FB1 (50 mM) and then inoculated with the virus solution (A/Memphis/1/71). Additional treatment for 20 h with FB1 after virus inoculation was carried out to cells pretreated for 24 h. The cells were fixed for 10 min with 1.6% paraformaldehyde in the culture medium. Fixed cells were incubated for 30 min in a solution containing anti-HA monoclonal antibody (12CA5), and were then incubated in a solution containing TRITC-conjugated goat anti-mouse IgG. Fluoromicroscopic analysis was performed using a confocal laser scanning microscope system, LS510 (Carl Zeiss Co., Ltd.).
RESULTS AND DISCUSSION
To further investigate participation of GSLs in the infection of influenza viruses to the host cells, we used two different metabolic inhibitors for the synthesis of sphingolipids. FB1 inhibits the formation of dihydroceramide from dihydrosphingosine. 21, 22) PDMP inhibits glucosyltransferase responsible for glucosylceramide synthesis.
23) The treatment with inhibitors was carried out by two different protocols as follows (Chart 1). The results obtained by the "pretreatment" protocol exhibit the contribution of sphingolipids to the adsorption of influenza viruses to the host cell surface. On the other hand, the "pre-and post-treatment" ascertains the involvement of sphingolipids in both the life cycle of the viruses and the following infection steps. By pre-and posttreatment of the cells with the inhibitors, A/Memphis/1/71 (H3N2), the viral infection was significantly suppressed in a dose dependent manner (Fig. 1A) . The pretreatment alone, however did not affect the viral infection although the length of inhibitor treatment was almost equal (Fig. 1B) . To confirm the effect of shphingolipid inhibitors on influenza virus infection, another inhibitor was used for the infection experiment. It is reported that N-(n-butyl)deoxynojirimycin (NB-DNJ) inhibits glucosyltransferase involved in glucosylceramide biosynthesis, resulting in reduction of cellular GSL contents. 37) When MDCK cells were pre-and post-treated with NB-DNJ at the same concentrations, the viral infection was also suppressed in a dose dependent manner. The infection of A/Memphis/1/71 was reduced to 80.9% and 45.5% of control by the treatment with NB-DNJ at 25 and 50 mM, respectively. On the other hand, when the cells were pretreated alone for 48 h with NB-DNJ at the same concentrations, the viral infection was not affected (101.6% and 95.6% of control by the treatment with NB-DNJ at 25 and 50 mM, respectively). We further examined whether the pre-and post-treatment with the inhibitors reduces the infection of different (sub)types of influenza viruses. In Fig. 2 , the pre-and posttreatment similarly inhibited the infection of both A/PR/8/34 (H1N1) and B/Lee/40, indicating that the action of the inhibitors is not restricted among the (sub)types of influenza viruses. Taken together, additional treatment with the inhibitors after viral inoculation, but not pretreatment alone is effective on the infection of influenza viruses. Furthermore, our findings strongly suggest that sphingolipids are critically involved in viral maturation after viral adsorption to the host cells.
To confirm the action of the inhibitors, we investigated the alteration of the lipid composition by the treatment with inhibitors. At 48 h post treatment of the cells with either inhibitor, the amount of GSLs was significantly reduced as compared to control treatment (DMSO) (Fig. 3A) . The relative ratio of a representative GSL, GM3 among GSLs was around 50% of control (Fig. 3B) . In phospholipids, sphingomyelin (SM) was drastically suppressed to 20% of control when the cells were treated with FB1, but not PDMP (Fig. 4) . There were no differences among other phospholipids. The amount of cholesterol was not altered by the treatment with the inhibitors (data not shown). The above results indicate that the treatment of both inhibitors was expectedly effective under our conditions. We did not observe any inhibition of viral infection when the cells were pretreated alone for 48 h with the inhibitors (Fig. 1B) although cellular sphingolipids including gangliosides were significantly reduced. We thus tested whether the attachment of the virus to MDCK cells is affected by the treatment with FB1. The ratios of viral attachment by the pre-and post-treatment and the pretreatment alone was 87.2Ϯ3.5% and 90.6Ϯ5.0% to control (DMSO treatment), respectively. Therefore, neither treatment condition significantly affected the binding of the virus to the host cell surface under our experimental conditions. By western blotting analysis, we also examined the synthesis of a viral glycoprotein, HA in MDCK cells treated during pre-and post viral inoculation or pretreated alone with FB1. The protein expression of HA was not reduced by either treatment with 50 mM of FB1 (Fig. 5) , implicating that FB1 treatment does not suppress protein synthesis of viral glycoproteins.
Recent studies exhibited that sphingolipids are involved in vesicular trafficking to the apical surface of epithelial cells [12] [13] [14] [15] [16] [17] [18] and that the interaction of transmembrane domain of HA with sphingolipids is related with the trafficking of this molecule to the apical surface. 13, 14) We hypothesized that cellular distribution of viral proteins disturbed by continuous reduction of sphingolipids may result in the inhibition of viral infection. Immunocytochemical analysis clearly demonstrated that cellular distribution of HA in the cells continuously treated with FB1 (pre-and post-treatment) is significantly different from that in the cells treated with DMSO (Fig. 6) . In DMSO treatment, the cells are not uniformly stained with the antibody. HA is predominantly localized on endoplasmic reticulum, Golgi-body, and plasma membrane in good agreement with previous studies. 19, 20) On the other hand, in the pre-and post-treated cells, bigger patched signals of HA are dispersed in the entire cytoplasmic region. Particularly, signals of HA are vague at the edges of the cells pre-and post-treated with FB1, strongly suggesting that the signals on the cell surface disappear. In polarized cells like MDCK, HA protein was found in detergent-insoluble glycol(sphingo)lipids (DIG) during transport to the cell surface. 15) Hemaggulutinin is soluble in the endoplasmic reticulum and is then associated with lipid microdomains like DIG after transport to the Golgi complex. Finally HA is transported from trans-Golgi network to plasma membrane and expressed on the cell surface with continuous association with the lipid microdomains. 13, 15) In our result, dispersed signals of HA in entire cytoplasmic region of the cells treated with FB1 suggest that reduction of cellular glycosphingolipids not only loses function of apical transport machinery but also diminish expression of HA on the cell surface, resulting in aberrant distribution of HA in MDCK cells.
There were no different signals from control in cells pretreated alone with FB1 for 44 h, followed by incubation for 20 h in the medium lacking FB1. In these conditions, the level of sphigolipids was nearly restored to control (data not shown). These observations suggest that continuous reduction of sphingolipids inhibits normal cellular distribution of viral proteins.
The effect of PDMP was slightly stronger than that of FB1 on viral infection (Figs. 1, 2) . Their effectiveness was concomitant with the reduction of GSLs, but not SM (Figs. 3, 4) , suggesting that GSLs may contribute to the viral infection more potently than SM in this study. As all GSLs detected were similarly reduced, it is not yet clear which species of GSLs dominantly participate in the viral infection. Previous studies reported that the bulk of sphingolipids, but not exclusive molecules contribute to the cell-substratum adhesion. 27) In sphingolipid-enriched microdomains, there are various types of glycosphingolipids existed. 12, 15, 27) We suppose that whole glycosphingolipids in MDCK may be involved in the events after viral adsorption.
Although several lines of evidence show that some gangliosides act as receptors for influenza viruses, [8] [9] [10] [11] no inhibition of viral attachment to the cells pretreated alone with the inhibitors were observed. There are two possible explanations. First, as the inhibition of GSLs was still 50% of control, the remaining GSLs may be sufficient for viral adsorption in normal. Second, it was reported that glycoproteins also possess receptor activities. [29] [30] [31] [32] [33] GSLs and glycoproteins may be redundant receptors and compensate each other to act as receptors for influenza viruses.
Previous studies demonstrated that alterations of lipid composition in the membrane strongly affect the membrane fusion induced by hemagglutinin of influenza viruses. [34] [35] [36] We determined that initial attachment of viruses to the host cells and the subsequent biosynthesis of a viral protein, HA in the host cells are not altered as compared to the control. Furthermore, as trypsin was not added in the media post viral inoculation in our assays, progeny viral particles released from the cells which were primarily infected with parental viruses can not infect the other cells. These data imply that the low level of sphingolipid concentration on the host cell surface does not inhibit the fusion between plasma mem- The cells were pretreated with FB1 (50 mM) for 24 or 48 h. The virus (A/Memphis/1/71) was inoculated into the culture and the cells were cultured for 20 h in the presence or absence of FB1 at the same concentration. The cells were then lysed in a buffer containing 1% Triton X-100, 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 10 mg/ml pepstatin A, 25 mM Tris buffer (pH 7.5). The lysates were subjected to SDS-PAGE, followed by western blotting with anti-HA monoclonal antibody (12CA5). Signals were detected by chemiluminescence method. brane and either parental or progeny virus particles. We suppose that the reduction of cellular sphingolipids might directly affect the vesicular trafficking in which viral proteins such as hemagglutinin and neuraminidase are transported to the apical membrane of MDCK cells, or the assembly of viral proteins as described previously. [12] [13] [14] [15] [16] [17] [18] In conclusion, GSLs are indispensable components for the life cycle of influenza viruses, which contribute to not only virus binding but also other critical steps of viral maturation, such as trafficking and assembly of viral proteins. Also, metabolic inhibitors against cellular sphingolipids are potentially new antiviral agents that can be used to prevent and treat influenza virus infection.
